Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors

NCT03101488 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

287

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: KN035

Sponsor

3D Medicines (Sichuan) Co., Ltd.